Yahoo HomeReggie Miller congratulates Steph Curry
Steph Curry passes Reggie Miller for 2nd on the All-Time 3PM list.
Make Yahoo Your Homepage
Discover something new every day from News, Sports, Finance, Entertainment and more!
Steph Curry passes Reggie Miller for 2nd on the All-Time 3PM list.
The "Piling Machine Market Trends, Growth & Analysis, by Product, by Method, by Application, by Region, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
In Japan, convenience is king and getting tested for COVID-19 can be highly inconvenient. Part of solution, as it is for a range of daily necessities in Tokyo, has become the humble vending machine. Eager to conserve manpower and hospital resources, the government conducts just 40,000 polymerase chain reaction (PCR) tests a day, a quarter of its capacity, restricting them to people who are quite symptomatic or have had a high chance of being infected.
The "Hepatitis D - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
Research Institutes of Sweden has decided that Sweden's largest testbed facility for electric vehicles will be located at Säve in Gothenburg. Construction of a building of almost 15,000 square meters will start soon.
The Duke and Duchess of Sussex made a number of revelations about the royal family.
Pepé Le Pew's scenes were reportedly cut from the film, which stars LeBron James.
The "Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
XPeng Inc. ("XPeng" or the "Company", NYSE: XPEV), a leading Chinese smart electric vehicle ("Smart EV") company, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.
Summary HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" - https://www.reportlinker.com/p05948866/?utm_source=GNW The model discusses in detail the impact of COVID-19 on HIV Tests market for the year 2020 and beyond.HIV is an ongoing, global public health issue that remains a major priority for most governments.HIV tests are performed for two purposes: i) screening and diagnosis; or ii) monitoring of HIV-positive patients, particularly those undergoing antiretroviral therapy (ART).Screening of pregnant women for HIV is standard of care in most countries and considered to be a cost-effective strategy for reducing the risk of transmission to the baby.Women are typically screened during their first trimester of pregnancy.For pregnant women at high-risk of acquiring HIV, testing is sometimes repeated at the beginning of the third trimester (28 weeks) or at the time of delivery.The HIV diagnostic tests include POC, NAAT, Multi-parameter NAAT and EIA tests.The HIV monitoring tests include NAAT for Viral Load and CD4 Count Tests.Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).Moreover, analyst comments with qualitative insight offer context for quantitative data.Key Inclusions of the market model are -Currently marketed HIV Tests and evolving competitive landscape -- Insightful review of the key industry trends.- Annualized total HIV Tests market revenue by segment and market outlooks from 2015-2030.- Granular data on total procedures, units, average selling prices and market values by segment.Global, Regional and Country level market specific insights -- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.- SWOT analysis for HIV Tests market.- Competitive dynamics insights and trends provided for HIV Tests market.Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.- Country specific overview of the healthcare system.- Country specific reimbursement policies.- Country specific medtech regulatory landscape.Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.Companies covered: Abbott Laboratories , F. Hoffmann-La Roche Ltd , Siemens Healthineers AG , Bio-Rad Laboratories Inc , Becton Dickinson and Co , OraSure Technologies Inc and OthersCountries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.ScopeThis Market Model gives important, expert insight you won’t find in any other source.The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -- CMO executives who must have deep understanding of the HIV Tests market place to make strategic planning and investment decisions.- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.Reasons to BuyThe model will enable you to -- Understand the impact of COVID-19 on HIV Tests market.- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving HIV Tests market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HIV Tests market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Track device sales in the global and country-specific HIV Tests market from 2015-2030.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p05948866/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Uncertainity over British-Iranian mother’s fate continues as she faces new charges days after release
The "Supermarkets and Hypermarkets Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Agriculture Analytics Market by Component, Application, Deployment, Farm Size, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The agriculture analytics market is expected to reach $2.27 billion by 2027, growing at a CAGR of 17.5% during the forecast period of 2020 to 2027. The growth of this market is mainly attributed to the rising adoption of advanced analytics, data-driven decision-making techniques, and growing digitalization in the agriculture industry.In 2020, based on component, the solutions segment is expected to account for the largest share of the agriculture analytics market. The large share of this segment is mainly attributed to the growing demand for high-quality food products that enable farmers to solve modern analytics techniques and approach traditional problems in modern ways.In 2020, based on deployment type, the cloud segment is expected to dominate the market. The large share is primarily attributed to the wide use of cloud computing across the agriculture industry for developing various solutions hosted on cloud platforms.In 2020, based on application, the farm analytics segment is poised to account for the largest share of the agriculture analytics market. The growth of this segment is primarily accredited to the growing traction of farmers on precision agriculture to use modern technology for numerous agricultural applications. Besides, the livestock analytics segment is projected to witness a high growth rate in the coming years.In 2020, based on farm size, the large-size farms segment is expected to account for the largest share of the agriculture analytics market. The growing spending capacity of owners of large farms on technology upgradations and the urge to establish a competitive edge in the agriculture industry are factors driving this segment. The market is geographically segmented into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. In 2020, North America is projected to command the largest share of the agriculture analytics market. However, Asia-Pacific is expected to witness rapid growth during the forecast period. This can be attributed to the increasing adoption of data analytics solutions across various agricultural countries such as China, India, South East Asia, and Japan.Key questions answered in the report: Which are the high growth market segments in terms of the component, deployment, application, farm-size, and countries?What is the historical market for agriculture analytics across the globe?What are the market forecasts and estimates from 2019-2027?Who are the major players in various countries, and what share of the market do they hold?What are the recent developments in the agriculture analytics market?What are the different strategies adopted by the major players in the agriculture analytics market?What are the geographical trends and high growth countries?Who are the local emerging players in the agriculture analytics market, and how do they compete with the other players? Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary3.1. Market Analysis, by Component 3.2. Market Analysis, by Application 3.3. Market Analysis, by Deployment 3.4. Market Analysis, by Farm Size 3.5. Market Analysis, by Geography 3.6. Competitive Analysis 4 Market Insights 4.1. Introduction 4.2. Drivers 4.2.1. Increasing Demand for Digital Agriculture Solutions and Services 4.2.2. Government Initiatives for Deploying Agriculture Techniques 4.2.3. Rising Pressure to Meet Global Food Demand 4.3. Restraints 4.3.1. Lack of Awareness About Precision Farming 4.3.2. Risks Associated with Data Security and Privacy 4.4. Opportunities 4.4.1. Growing Adoption of Smart Technologies to Enable Precision Agriculture 4.4.2. Increasing Adoption of Ai and Predictive Analytics to Improve the Yield 4.5. Challenges 4.5.1. Lack of Technically Skilled Farmers 4.5.2. Lack of Standardization for Data Management and Data Aggregation Agriculture Industry 4.6. Trends 4.6.1. Increase in Number of Start-Up Companies in Agri-Tech Industry 4.7. Impact of Covid-19 Pandemic on Agriculture Analytics Market 5 Agriculture Analytics Market, by Component 5.1. Introduction 5.2. Software 5.3. Services 5.3.1. Professional Services 5.3.1.1. Integration and Implementation Services 5.3.1.2. Support and Maintenance Services 5.3.1.3. Consulting Services 5.3.1.4. Training and Education Services 5.3.2. Managed Services 6 Agriculture Analytics Market, by Application 6.1. Introduction 6.2. Farm Analytics 6.2.1. Farm Production 6.2.1.1. Crop Growth and Health 6.2.1.2. Irrigation and Water Management 6.2.1.3. Fertilizer Management 6.2.1.4. Farm Labor Management 6.2.2. Planning 6.2.2.1. Crop Scouting 6.2.2.2. Field Mapping 6.2.2.3. Weather Data Analytics 6.2.2.4. Soil Moisture Analysis 6.2.3. Post-Harvest Activities 6.2.3.1. Storage 6.2.3.2. Market Access 6.2.3.3. Processing 6.2.3.4. Transport 6.3. Livestock Analytics 6.3.1. Feeding Management 6.3.2. Heat Stress and Fertility Management 6.3.3. Milk Harvesting 6.3.4. Behavior Monitoring and Management 6.3.5. Other Applications 6.4. Aquaculture Analytics 6.4.1. Water Quality Management 6.4.2. Fish Tracking and Fleet Navigation 6.4.3. Feed Management 6.4.4. Other Applications in Aquaculture Analytics 6.5. Other Applications in Agriculture Analytics 7 Agriculture Analytics Market, by Deployment Type 7.1. Introduction 7.2. Cloud-Based 7.3. On-Premise 8 Agriculture Analytics Market, by Farm Size 8.1. Introduction 8.2. Large-Sized Farms 8.3. Small and Medium-Sized Farms 9 Agriculture Analytics Market, by Geography 10 Competitive Landscape10.1. Introduction 10.2. Key Growth Strategies 10.3. Competitive Benchmarking 10.4. Market Share Analysis 11 Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)11.1. Deere & Company 11.2. Trimble, Inc. 11.3. DeLaval, Inc. 11.4. Farmers Edge, Inc. 11.5. IBM Corporation 11.6. Sap SE11.7. Oracle Corporation 11.8. AgEagle Aerial Systems, Inc. 11.9. Agrivi 11.10. AgVue Technologies 11.11. aWhere, Inc. 11.12. Conservis Corporation 11.13. DTN 11.14. Farmer's Business Network, Inc. 11.15. Accenture PLC 11.16. Bayer AG 11.17. Geosys Intl, Inc. (A Part of Urthecast)For more information about this report visit https://www.researchandmarkets.com/r/3yuxz2 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The government has released dates for when gyms, hairdressers, schools, pubs, restaurants and more will reopen
Being a medical professional in the country is a terrifying experience. Working among rubble, at risk of imminent shelling, and treating patients with horrific injuries is part of daily life
The "Ibuprofen API Market Research and Outlook, 2020 - Trends, Growth Opportunities and Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering.
Kite, a unit of Gilead Sciences, announced that the US Food and Drug Administration (FDA) has approved its Yescarta T cell immunotherapy. The therapy is a first-of-its-kind treatment for adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. The Gilead (GILD) company said that the US regulator’s decision was based on ZUMA-5, a single-arm, open-label study, that demonstrated 91% of patients with relapsed or refractory FL (n=81) responded to Yescarta. Shares of the biopharmaceutical company increased 2.2% to close at $64.62 on March 5. Kite CEO Christi Shaw said, “As we look to bring the hope of survival to more patients in need, today’s FDA decision represents a real step forward in our commitment in hematologic malignancies.” (See Gilead stock analysis on TipRanks) “Advancing CAR T therapies for patients across lymphomas remains a cornerstone of our cell therapy development program, and we are excited about the potential of Yescarta for patients with indolent follicular lymphoma,” Shaw added. On Feb. 10, Mizuho Securities analyst Salim Syed maintained a Buy rating and a price target of $81 (25.4% upside potential) on the stock after Galapagos and Gilead discontinued ISABELA Phase 3 clinical studies. The rest of the Street is cautiously optimistic about the stock with a Moderate Buy consensus rating. That’s based on 11 analysts suggesting a Buy, 9 analysts recommending a Hold and 1 analyst suggest a Sell. The average analyst price target of $75.73 implies 17.2% upside potential to current levels. Shares have increased 7.5% so far this year. Related News: Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79% Kroger Tops 4Q Profit Estimates As Online Sales Spike 118%; Shares Gain BlueLinx Posts Blowout Quarter; Stock Rises 9% More recent articles from Smarter Analyst: Chevron Inks Deal To Buy Noble Midstream Partners; Shares Gain 4% Abbott’s Alinity m Resp-4-Plex Test Cleared For Emergency Use In US; Street Says Buy Eli Lilly Wins EMA Nod For COVID-19 Antibody Therapy; Shares Jump 3% GE To Combine GECAS Business With AerCap – Report
Deutsche Bank dubbed it a 'spend now, pay later' budget.
As per the published report, the global COVID-19 detection kits market is estimated to arrive at USD 4.63 billion by 2027. It is anticipated to record 5.05% CAGR in the period of the forecast.
Publicity surrounding film’s release in China has been removed from social media
Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948871/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond.Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis.In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain.Gonorrhea is one of the most common sexually transmitted disease (STD) worldwide, caused by the bacteria Neisseria gonorrhoeae. N. gonorrhoeae infections are more common in young adults. Other groups at higher risk of contracting gonorrhea include individuals with multiple sexual partners, individuals with another STD, men who have sex with men (MSM), and sex workers. Model covers Dual CT/NG Multiparameter NAAT testing.Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).Moreover, analyst comments with qualitative insight offer context for quantitative data.Key Inclusions of the market model are -Currently marketed Multiparameter CT/NG NAAT Tests and evolving competitive landscape -- Insightful review of the key industry trends.- Annualized total Multiparameter CT/NG NAAT Tests market revenue by segment and market outlooks from 2015-2030.- Granular data on total procedures, units, average selling prices and market values by segment.Global, Regional and Country level market specific insights -- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.- SWOT analysis for Multiparameter CT/NG NAAT Tests market.- Competitive dynamics insights and trends provided for Multiparameter CT/NG NAAT Tests market.Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.- Country specific overview of the healthcare system.- Country specific reimbursement policies.- Country specific medtech regulatory landscape.Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.Companies covered: Hologic Inc, Danaher Corp, F. Hoffman La Roche Ltd., Abbott Labs, Becton Dickinson and Co and OthersCountries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.ScopeThis Market Model gives important, expert insight you won’t find in any other source.The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -- CMO executives who must have deep understanding of the Multiparameter CT/NG NAAT Tests market place to make strategic planning and investment decisions.- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.Reasons to BuyThe model will enable you to -- Understand the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market.- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving Multiparameter CT/NG NAAT Tests market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Multiparameter CT/NG NAAT Tests market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Track device sales in the global and country-specific Multiparameter CT/NG NAAT Tests market from 2015-2030- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p05948871/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001